Log in
Enquire now
‌

US Patent 10376557 Peptide fragments for inducing synthesis of extracellular matrix proteins

Patent 10376557 was granted and assigned to HELIX BIOMEDIX on August, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
HELIX BIOMEDIX
HELIX BIOMEDIX
Current Assignee
HELIX BIOMEDIX
HELIX BIOMEDIX
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10376557
Patent Inventor Names
Timothy J. Falla0
Lijuan Zhang0
Scott M. Harris0
Date of Patent
August 13, 2019
Patent Application Number
15239708
Date Filed
August 17, 2016
Patent Primary Examiner
‌
Amber D Steele
Patent abstract

Short biologically active tetrapeptides are disclosed that are comprised of the sequences GxxG and PxxP where G (glycine) and P (proline) are maintained and x is a variable amino acid. The peptides can be used singly or in combination to stimulate production of extracellular matrix proteins in skin. A rapid, low-cost method of producing heterogenous formulations of tetrapeptides is disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10376557 Peptide fragments for inducing synthesis of extracellular matrix proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us